E20.818
Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
Clinical Classification Guidelines
Inclusion Terms
- Familial isolated hypoparathyroidism
Medical Intelligence & Overview
Other specified hypoparathyroidism, classified under ICD-10 code E20.818, is a condition characterized by insufficient production or secretion of parathyroid hormone (PTH) by the parathyroid glands. Unlike other types of hypoparathyroidism, this condition is specifically noted for impairments in hormone secretion, which plays a vital role in regulating calcium and phosphate levels in the body. It can be a familial disorder or occur due to other underlying causes, leading to disturbances in calcium balance that affect many bodily functions.
Causes & Symptoms
Clinical Causes: Genetic factors, such as familial isolated hypoparathyroidism Impaired function or development of the parathyroid glands Autoimmune destruction of parathyroid tissue Infiltrative diseases affecting the glands Surgical removal or damage during neck surgeries Certain genetic syndromes or mutations affecting hormone secretion Other rare causes leading to disruption in PTH secretion
Key Symptoms: Muscle cramps and spasms (tetany) Paresthesias, especially around the mouth and in extremities Fatigue and weakness Depressive or anxious mood Difficulty concentrating Hair loss or brittle nails Seizures in severe cases Calcifications in the brain or other tissues Chvostek sign (facial muscle twitching when facial nerve is tapped) Trousseau sign (muscle twitching with blood pressure cuff inflation)
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory testing. Key diagnostic steps include: - Measuring serum calcium and phosphate levels, which are often low in hypoparathyroidism - Assessing serum parathyroid hormone (PTH) levels, which are decreased or inappropriately normal in cases of impaired secretion - Checking for calcium and vitamin D levels to rule out other causes of calcium imbalance - Possibly imaging studies of the parathyroid glands if structural abnormalities are suspected - Genetic testing may be considered in familial cases to identify specific mutations Diagnosis aims to confirm impaired PTH secretion and differentiate this condition from other causes of hypocalcemia.
Treatment Protocols: Management of this condition focuses on correcting calcium levels and preventing symptoms. Typical approaches include: - Oral calcium supplements to raise blood calcium levels - Active forms of vitamin D (such as calcitriol) to enhance calcium absorption - Monitoring serum calcium and adjusting treatment accordingly - Use of magnesium supplements if magnesium deficiency contributes to impaired PTH secretion - In some cases, recombinant PTH therapy may be considered - Dietary modifications to ensure adequate calcium intake - Regular follow-up with healthcare providers to monitor biochemical parameters and prevent complications It is important to tailor treatment to individual needs and to carefully manage therapy to avoid hypercalcemia and related issues.
Clinical Advice & FAQs
Billing Guidance
Is E20.818 a billable ICD-10 code?
Yes, E20.818 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E20.818?
Clinical documentation must specify the nature of Other specified hypoparathyroidism due to impaired parathyroid hormone secretion and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
